Skip to content

Efficacy and safety of ENDOANGEL in the auxiliary identification of early esophageal cancer: a prospective, randomized, single-blind, parallel-controlled multicenter study

Efficacy and safety of ENDOANGEL in the auxiliary identification of early esophageal cancer: a prospective, randomized, single-blind, parallel-controlled multicenter study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041948
Enrollment
Unknown
Registered
2021-01-10
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early esophageal carcinoma

Interventions

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Males or females who are over 18 years old (inclusive); 2) Patients who need to undergo esophageal endoscopic examination, that is, suspected esophageal neoplastic lesions, require preoperative staining magnifying endoscopy to assess the nature of the lesion and the depth of invasion; 3) Able to read, understand and sign informed consent forms; 4) The researcher believes that the subject can understand the process of the clinical research, is willing and able to complete all research procedures and follow-up visits, and cooperate with the research procedures.

Exclusion criteria

Exclusion criteria: 1) Participated in other clinical trials, signed an informed consent form and within the follow-up period of other clinical trials; 2) Participated in drug clinical trials, and within the washout period of test drugs or control drugs; 3) Abuse of drugs or alcohol or mental disorders in the last 5 years; 4) Women during pregnancy or breastfeeding; 5) Subjects with previous history of esophageal surgery; 6) Allergies to pre-used anesthetics in previous medical history; 7) The researcher believes that the subject is not suitable for painless upper gastrointestinal endoscopy; 8) The investigator believes that the subject is not suitable for high-risk diseases or other special circumstances to participate in clinical trials.

Design outcomes

Primary

MeasureTime frame
Accuracy;

Secondary

MeasureTime frame
Sensitivity;Specificity;

Countries

China

Contacts

Public ContactLiu Mei

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

1744634750@qq.com+86 18627714881

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026